Your browser doesn't support javascript.
loading
Anti-InlA single-domain antibodies that inhibit the cell invasion of Listeria monocytogenes.
Yamazaki, Taichi; Nagatoishi, Satoru; Yamawaki, Tsukushi; Nozawa, Takashi; Matsunaga, Ryo; Nakakido, Makoto; Caaveiro, Jose M M; Nakagawa, Ichiro; Tsumoto, Kouhei.
Afiliação
  • Yamazaki T; Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan.
  • Nagatoishi S; Medical Device Development and Regulation Research Center, School of Engineering, The University of Tokyo, Tokyo, Japan. Electronic address: s-nagatoishi@g.ecc.u-tokyo.ac.jp.
  • Yamawaki T; Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo, Japan.
  • Nozawa T; Department of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Matsunaga R; Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan.
  • Nakakido M; Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan.
  • Caaveiro JMM; Laboratory of Global Healthcare, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • Nakagawa I; Department of Microbiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tsumoto K; Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan; Medical Device Development and Regulation Research Center, School of Engineering, The University of Tokyo, Tokyo, Japan; Department of Chemistry and Biotechnology, School of Engineering, The University of Tok
J Biol Chem ; 299(10): 105254, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37716701
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article